TOPRA is Association Partner at GCC Pharma Summit 2024

Posted on 11 March 2024

TOPRA has been confirmed as an Association Partner for the 9th GCC Regulatory Affairs Pharma Summit. Taking place on 22-26 April 2024 in Dubai, UAE, the GCC Summit is a pioneering platform in the region, uniting government representatives, industry leaders, and solution providers to delve into the latest regulations shaping the pharmaceutical landscape.

With the theme of ‘Navigate Pharma Regulations with ease & Amplify Commercial Success’, this 5 day summit will include the following events and training sessions: 

  • 22-23 April – GCC Regulatory Affairs Pharma Summit
  • 24-25 April – GCC Pharmacovigilance Training 
  • 24-25 April – GCC Medical Tender & Business Talk 
  • 26 April – GCC Quality Conference 
  • 26 April – eCTD Training

The agenda will feature immersive workshops and roundtable discussions centered on key topics such as regulatory digital transformation and data safety, pharma manufacturing in the GCC, track and trace, reliance, and regional regulatory updates in the Gulf Cooperation Council (GCC) region. 

Sponsors and exhibitors include industry-leading companies such as AbbVie, ACG Inspection, Bayer, Cosmotrace, Evoteq, Extedo, Hikma Pharmaceuticals, Honeywell, Ipsen, Julphar, PI Pharma Intelligence, RAS LSS, RegOrbit, Sanofi, Schlafender Hase, Inc., State of Practices Consultancy Center (SOP), Tabuk, Takeda, and VISIOTT Traceable Packaging Solutions. 

As an Association Partner, TOPRA has also arranged for members to get 20% discount on GCC Regulatory Affairs Pharma Summit 2024 registration fees – please email us at for more information.  

TOPRA Chief Executive, Kevin Pay, said: “We are delighted to join the GCC Summit 2024’s roster of Association Partners and to support this important event for pharma and medical device professionals. We at TOPRA are dedicated to supporting regulatory affairs professionals across the globe, and see our partnership and attendance as the ideal opportunity to build new relationships with pharma colleagues and organisations.” 

Co-Founder and Managing Director of PRA Consultancy, Dr Mona Al Moussli, said: "Effortlessly navigating pharmaceutical regulations and maximising commercial success is paramount for the betterment of the industry, specifically since the pharmaceutical industry is on a continuous-commercial growth. By staying informed and embracing networking opportunities, professionals can excel in this dynamic industry landscape. The GCC Summit facilitates this by providing invaluable insights into regulatory compliance and strategies for enhancing commercial outcomes.”